Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioventus Inc BVS

Healthcare Medical Instruments & Supplies
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products... see more

Recent & Breaking News (NDAQ:BVS)

Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023

GlobeNewswire October 31, 2023

Bioventus to Present at the Cantor Global Healthcare Conference

GlobeNewswire September 19, 2023

Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

GlobeNewswire September 6, 2023

Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance

GlobeNewswire August 8, 2023

Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference

GlobeNewswire August 4, 2023

Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023

GlobeNewswire August 1, 2023

Bioventus Completes Divestiture of its Wound Business

GlobeNewswire May 23, 2023

Bioventus Reports First Quarter Financial Results

GlobeNewswire May 16, 2023

Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023

GlobeNewswire May 15, 2023

Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023

GlobeNewswire May 11, 2023

Bioventus Announces Divestiture of its Wound Business

GlobeNewswire May 10, 2023

Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

GlobeNewswire May 3, 2023

Bioventus Announces CEO Leadership Change

GlobeNewswire April 5, 2023

Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results

GlobeNewswire March 31, 2023

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

GlobeNewswire March 31, 2023

Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023

GlobeNewswire March 29, 2023

Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

GlobeNewswire March 16, 2023

SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

PR Newswire March 13, 2023

Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Bioventus Inc. (BVS) Investors of Class Action and Last Few Hours to Actively Participate

Business Wire March 13, 2023

BVS DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Bioventus Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - BVS

Newsfile March 13, 2023